Represents the Company’s tenth product launch since inception in October 2023 SCHAUMBURG, Ill., June 24, 2024--(BUSINESS WIRE)--Avenacy, a specialty pharmaceutical company focused on supplying ...

Mylan has issued a nationwide voluntary recall of injectable amiodarone, an antiarrhythmic for in-hospital use, that may have been mislabeled as tranexamic acid injection, according to the US Food and ...

Credit: FDA. The FDA has received reports of tranexamic acid injection being erroneously administered intrathecally in the perioperative setting instead of the intended intrathecal anesthetic (eg, ...

Inadvertent administration may result in serious adverse events. Mylan announced the voluntary recall to the hospital/clinic level of 4 lots of Amiodarone HCl Injection, USP 450mg/9mL and Tranexamic ...

Mylan N.V. (NASDAQ: MYL) today announced that its U.S.-based Mylan Institutional LLC business is conducting a voluntary nationwide recall to the hospital/clinic level of four lots of Amiodarone HCl ...

The FDA is requiring updated labeling for tranexamic acid injection to emphasize the risk of serious harm, including death, if administered incorrectly via spinal injection. Tranexamic acid injection ...

Acella Pharmaceuticals, LLC, a specialty pharmaceutical company, announces the approval of an Abbreviated New Drug Application (ANDA) 1 for Tranexamic Acid Injection 1000 mg/10mL (100 mg/mL). The Food ...

The Institute for Safe Medication Practices added tranexamic acid injection solutions to its high-alert medications list, which registers drugs linked with a high ...

SCHAUMBURG, Ill.--(BUSINESS WIRE)--Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced it has launched Tranexamic Acid Injection, USP in ...